The Abbott™ Amplatzer™ Structural Intervention devices provide a comprehensive portfolio dedicated to enhancing patient safety. With a proven track record of clinical efficacy spanning two decades, it continues to lead the way in global innovation and treatment standards.
Introducing the Amplatzer™ Portfolio App, designed to streamline device utilization. This innovative tool allows users to input defect information based on imaging data, with the app then recommending suitable devices according to the provided Instructions for Use (IFU). The app is cost-free, compatible with both smartphones and tablets, and functions seamlessly even in offline settings.
- Amplatzer™ portfolio
- Kept constantly updated
- Displays the complete range of devices available in your geographical area
- Accessible online and offline
- Compatible with smartphones and tablets
Overview
Amplatzer™ Portfolio is a Freeware software in the category Home & Hobby developed by Abbott.
The latest version of Amplatzer™ Portfolio is 3.2.1, released on 05/10/2024. It was initially added to our database on 05/10/2024.
Amplatzer™ Portfolio runs on the following operating systems: iOS.
Users of Amplatzer™ Portfolio gave it a rating of 5 out of 5 stars.
Pros
- Offers a range of devices and solutions for structural heart disease, including atrial septal defect (ASD) closure devices, ventricular septal defect (VSD) closure devices, patent foramen ovale (PFO) closure devices, and left atrial appendage (LAA) occlusion devices.
- Many of the devices in the Amplatzer™ Portfolio have a strong clinical evidence base supporting their effectiveness and safety in various structural heart disease indications.
- Known for innovative technology and design, which can lead to better patient outcomes with reduced procedural complications.
- The Amplatzer™ Portfolio provides a comprehensive suite of tools and products that can cater to a wide range of structural heart disease procedures, giving healthcare providers more flexibility in treatment options.
Cons
- It can be costly to procure and maintain the devices in the Amplatzer™ Portfolio, potentially limiting accessibility for healthcare facilities with budget constraints.
- The deployment of certain Amplatzer™ devices requires specialized training and expertise, which could pose a challenge for healthcare providers who are not familiar with the technology.
- As with any medical device, there are risks of complications associated with the use of the Amplatzer™ devices, such as embolization, perforation, or device-related thrombosis.
FAQ
What is the Amplatzer™ Portfolio by Abbott?
The Amplatzer™ Portfolio by Abbott is a range of devices designed for minimally invasive structural heart therapy procedures.
What type of devices are included in the Amplatzer™ Portfolio?
The Amplatzer™ Portfolio includes devices such as septal occluders, vascular plugs, intracardiac plug systems, and other innovative solutions for structural heart interventions.
What are septal occluders used for?
Septal occluders are used to close holes in the heart, particularly atrial septal defects (ASDs) and patent foramen ovale (PFO).
How do vascular plugs work?
Vascular plugs are used to embolize blood vessels or close off abnormal connections in the vascular system. They have a self-expanding design that conforms to the vessel walls.
What are intracardiac plug systems used for?
Intracardiac plug systems are used for left atrial appendage closure to reduce the risk of stroke in patients with atrial fibrillation.
Are the devices in the Amplatzer™ Portfolio FDA approved?
Yes, the devices in the Amplatzer™ Portfolio by Abbott have received FDA approval for specific indications.
Can these devices be used in minimally invasive procedures?
Yes, the Amplatzer™ devices are specifically designed for minimally invasive procedures, offering less invasive options for patients.
Do these devices have a good track record of safety and efficacy?
The Amplatzer™ Portfolio by Abbott has a proven track record of safety and efficacy supported by clinical data and real-world experience.
Where can healthcare professionals get training on using these devices?
Abbott provides training programs and resources for healthcare professionals interested in using the Amplatzer™ Portfolio devices.
Are there any ongoing research or development efforts to expand the Amplatzer™ Portfolio?
Abbott continues to invest in research and development to expand the capabilities of the Amplatzer™ Portfolio and address evolving needs in structural heart therapy.
Screenshots (Click to view larger)
| 11/26/2024 | Diagnostics Download Manager 6.8.0.904 |
| 11/26/2024 | SteuerSparErklärung Steuerjahr 30.20.17 |
| 11/26/2024 | Eclipse Temurin JRE avec Hotspot 11.0.12+7 (x64) 11.0.22.7 |
| 11/26/2024 | osulazer 2024.1009.1 |
| 11/26/2024 | Atomic Heart 51.1052 |
| 11/26/2024 | Use a free UpdateStar Pack to setup your software in 2025 |
| 11/22/2024 | Wireshark 4.4.2 update available |
| 11/21/2024 | US government wants Google to sell the Chrome browser |
| 11/20/2024 | 7-Zip update fixes vulnerability |
| 11/20/2024 | Why use a VPN service in 2025? |
Latest Reviews
|
EasyEDA
EasyEDA - Simplify Your PCB Design Process |
|
 |
NTSMagicXMLSecurityNP
Protect Your XML Files with NTSMagicXMLSecurityNP |
|
Call of Duty: WWII
Experience the intensity of WWII battles in Call of Duty: WWII |
|
|
HsWebPlugin
Revolutionize Your Website with HsWebPlugin! |
|
|
eTransmit for Autodesk Revit 2017
Efficient file sharing and data transmission with eTransmit for Autodesk Revit 2017. |
|
 |
Lenovo VeriFace
Protect Your Data with Lenovo VeriFace Facial Recognition Software |
UpdateStar Premium Edition
Google Chrome
Microsoft Edge
Microsoft Visual C++ 2015 Redistributable Package
Microsoft Edge WebView2 Runtime
Microsoft Visual C++ 2010 Redistributable
